voriconazole IV
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Serious Fungal Infections
Conditions
Serious Fungal Infections
Trial Timeline
Mar 1, 2006 → Oct 1, 2009
NCT ID
NCT01073618About voriconazole IV
voriconazole IV is a pre-clinical stage product being developed by Pfizer for Serious Fungal Infections. The current trial status is completed. This product is registered under clinical trial identifier NCT01073618. Target conditions include Serious Fungal Infections.
What happened to similar drugs?
0 of 2 similar drugs in Serious Fungal Infections were approved
Approved (0) Terminated (1) Active (1)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01073618 | Pre-clinical | Completed |
Competing Products
4 competing products in Serious Fungal Infections
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Saizen® A + Saizen® B | Merck | Phase 3 | 40 |
| BAT | Pfizer | Phase 3 | 32 |
| voriconazole tablet | Pfizer | Pre-clinical | 26 |
| TD-1607 + Placebo | Theravance Biopharma | Phase 1 | 23 |